Published in Pediatr Infect Dis J on August 01, 1987
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Baby Check: a scoring system to grade the severity of acute systemic illness in babies under 6 months old. Arch Dis Child (1991) 5.37
Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. BMJ (2006) 3.48
Vaccine-related pain: randomised controlled trial of two injection techniques. Arch Dis Child (2007) 2.76
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I). Hum Vaccin Immunother (2014) 1.06
Effects of acetaminophen on adverse effects of influenza vaccination in health care workers. CMAJ (1993) 1.01
A randomized placebo-controlled trial of acetaminophen for prevention of post-vaccination fever in infants. PLoS One (2011) 1.00
Pertussis vaccine: myths and realities. Can Fam Physician (1988) 0.95
Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination. Infect Immun (2001) 0.90
The effect of prophylactic antipyretic administration on post-vaccination adverse reactions and antibody response in children: a systematic review. PLoS One (2014) 0.85
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Febrile seizures. Korean J Pediatr (2014) 0.78
Fever in Children: Should it be Treated? Can Fam Physician (1988) 0.76
Office-based research: A new era and new opportunities. Paediatr Child Health (2002) 0.75
Immunizations in pediatrics: an update. Can Fam Physician (1990) 0.75
Effects of Administering Prophylactic Acetaminophen on Short-term Complications of Vaccination in 6-month-old Infants. Int J Prev Med (2015) 0.75
Evaluation of Fever in a child aged three months to 24 months. Can Fam Physician (1990) 0.75
Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine. CMAJ (1994) 0.75
Statement on pertussis immunization. National Advisory Committee on Immunization. CMAJ (1993) 0.75
Effect of antipyretic analgesics on immune responses to vaccination. Hum Vaccin Immunother (2016) 0.75
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Development of a short 'readiness to change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. Br J Addict (1992) 5.02
Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med (1970) 4.90
Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis (1978) 4.00
Human herpesvirus 8 variants in sarcoid tissues. Lancet (1997) 3.87
Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med (1997) 3.32
Effect of neonatal circumcision on pain responses during vaccination in boys. Lancet (1995) 3.31
A requirement for phosphatidylinositol 3-kinase in pseudopod extension. J Biol Chem (1999) 3.08
Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90
Cutaneous reactions and antibody response to meningococcal group C polysaccharide vaccines in man. J Infect Dis (1970) 2.71
Leukemic phase of mantle cell lymphoma two case reports and review of the literature. Arch Pathol Lab Med (1996) 2.66
Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70. Bull World Health Organ (1971) 2.64
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort. Neurology (2012) 2.60
The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop Relat Res (1976) 2.46
Disseminated fusarial infection in the immunocompromised host. Rev Infect Dis (1989) 2.46
Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28
2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet (1997) 2.28
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology (2011) 2.26
Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24
Adverse reactions to diphtheria, tetanus, pertussis-polio vaccination at 18 months of age: effect of injection site and needle length. Pediatrics (1989) 2.21
Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis (1971) 2.17
Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J Clin Invest (1975) 2.16
Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth (2010) 2.15
Results from the 1995 National College Health Risk Behavior Survey. J Am Coll Health (1997) 2.13
A validation study on the use of intra-operative video recording as an objective assessment tool for core ENT surgery. Clin Otolaryngol (2014) 1.98
Aortoenteric fistula. Incidence, presentation recognition, and management. Ann Surg (1982) 1.97
[Fumaric acid as therapeutic agent for multiple sclerosis]. Nervenarzt (2014) 1.97
Where do medically qualified researchers come from? Lancet (1985) 1.96
Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. J Cell Biol (1988) 1.95
Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis. Brain (2001) 1.91
Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis (1998) 1.85
Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA (1995) 1.83
A requirement for ARF6 in Fcgamma receptor-mediated phagocytosis in macrophages. J Biol Chem (1998) 1.82
Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections. J Clin Epidemiol (2000) 1.82
Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J Clin Microbiol (2001) 1.80
A Rab11-containing rapidly recycling compartment in macrophages that promotes phagocytosis. Proc Natl Acad Sci U S A (2000) 1.79
ARF6 is required for growth factor- and rac-mediated membrane ruffling in macrophages at a stage distal to rac membrane targeting. Mol Cell Biol (1999) 1.73
Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. Am J Med (1992) 1.73
Survey of parents' attitudes to the recommended Haemophilus influenzae type b vaccine program. CMAJ (1987) 1.72
Screening for celiac disease in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr (2001) 1.70
Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J Infect Dis (1979) 1.67
Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol (2006) 1.62
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics (1977) 1.50
Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol (1993) 1.50
Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem (1994) 1.49
Encoding of amplitude modulation in the cochlear nucleus of the cat. J Neurophysiol (1994) 1.49
YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect Immun (1999) 1.49
Superficial siderosis of the central nervous system: pathogenetic heterogeneity and therapeutic approaches. Acta Neurol Scand (2003) 1.49
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J Neurol (2008) 1.46
["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients]. Nervenarzt (2010) 1.45
Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J Clin Microbiol (1980) 1.45
Neural temporal coding of low pitch. I. Human frequency-following responses to complex tones. Hear Res (1987) 1.42
A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases. Clin Orthop Relat Res (1985) 1.42
Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol (1991) 1.41
Intravenous Immunoglobulins in MS. Int MS J (2005) 1.41
Treating HIV encephalopathy with antiretroviral therapy: a clinical case demonstrating the success of HAART. Clin Infect Dis (2004) 1.41
Technology for mobility in SCI 10 years from now. Spinal Cord (2012) 1.39
Chronic recurrent multifocal osteomyelitis: a noninfectious inflammatory process. Pediatr Infect Dis J (1987) 1.37
Stimulus responses and amyloid precursor protein processing in DAMI megakaryocytes. J Lab Clin Med (1997) 1.37
Syk tyrosine kinase is required for immunoreceptor tyrosine activation motif-dependent actin assembly. J Biol Chem (1996) 1.36
Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system. Semin Immunol (2001) 1.36
Genome-sequence-based fluorescent amplified-fragment length polymorphism analysis of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.36
Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood (2000) 1.35
P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood (1994) 1.35
Giant axonal neuropathy. A clinically and morphologically distinct neurological disease. Arch Neurol (1974) 1.34
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31
A specific circulating antigen in hamsters infected with Schistosoma mansoni. Detection of antigen in serum and urine, and correlation between antigenic concentration and worm burden. Am J Trop Med Hyg (1969) 1.30
The sequelae of Haemophilus influenzae meningitis in school-age children. N Engl J Med (1990) 1.27
The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatr Infect Dis J (2000) 1.27
Nitric oxide is a signal for NNR-mediated transcription activation in Paracoccus denitrificans. J Bacteriol (1999) 1.26
Evaluation of a microprocessor-based portable home monitoring system to measure breathing during sleep. Sleep (1987) 1.23
Lateral suppression and inhibition in the cochlear nucleus of the cat. J Neurophysiol (1994) 1.23
Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA (2001) 1.22
Adenoviral pneumonia and its complications in infancy and childhood. J Can Assoc Radiol (1969) 1.20
A regulatory role for Src homology 2 domain-containing inositol 5'-phosphatase (SHIP) in phagocytosis mediated by Fc gamma receptors and complement receptor 3 (alpha(M)beta(2); CD11b/CD18). J Exp Med (2001) 1.20
Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. Pediatr Infect Dis (1985) 1.19
Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology (2004) 1.19
Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol (2001) 1.18
Use of lidocaine-prilocaine cream for vaccination pain in infants. J Pediatr (1994) 1.17
Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics (1986) 1.17
Reactions of 2-acyloxyisobutyryl halides with nucleosides. II. Reactions of adenosine. J Am Chem Soc (1973) 1.16
On-farm methane measurements during milking correlate with total methane production by individual dairy cows. J Dairy Sci (2012) 1.15
Fumaric Acid and its esters: an emerging treatment for multiple sclerosis. Curr Neuropharmacol (2009) 1.15
Controlled study of respiratory viruses and wheezing. Arch Dis Child (2002) 1.15
Rapid identification by specific PCR of coagulase-negative staphylococcal species important in hospital infection. J Med Microbiol (1997) 1.15
Diffusion of ions in myelinated nerve fibers. Biophys J (1979) 1.14
Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. J Infect Dis (1977) 1.13
Changes in total amount of stage four sleep as a function of partial sleep deprivation. Electroencephalogr Clin Neurophysiol (1966) 1.13
Resolution of ventricular tachycardia and endocardial tuberculoma following antituberculosis therapy. Chest (1991) 1.13
Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity. Mol Pharmacol (2001) 1.13
Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann N Y Acad Sci (1996) 1.13